Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

作者: Dale Han , Daniel C Thomas , Jonathan S Zager , Barbara Pockaj , Richard L White

DOI: 10.5306/WJCO.V7.I2.174

关键词: MelanomaSurgeryMetastasisMedicineRandomized controlled trialLymphadenectomyInternal medicineOncologyLymphBiopsySentinel lymph nodeWide local excision

摘要: An estimated 73870 people will be diagnosed with melanoma in the United States 2015, resulting 9940 deaths. The majority of patients cutaneous melanomas are cured wide local excision. However, current evidence supports use sentinel lymph node biopsy (SLNB) given 15%-20% who harbor regional metastasis. More importantly, presence or absence nodal micrometastases has been found to most important prognostic factor early-stage melanoma, particularly intermediate thickness melanoma. This review examines development SLNB for as a means determine patient's status, efficacy and biology metastatic nodes. Prospective randomized trials have guided practice guidelines shown value SLNB. Given rapidly advancing molecular surgical technologies, technical aspects diagnosis, identification, management nodes continues evolve improve. Additionally, there is ongoing research examining both role specific clinical scenarios ways identify may benefit from completion lymphadenectomy positive SLN. Until further data provides sufficient alter national consensus-based guidelines, remains standard care clinically node-negative

参考文章(171)
Brian M. Parrett, Mohammed Kashani-Sabet, Mark I. Singer, Rui Li, Suresh Thummala, Niloofar Fadaki, Stanley P. L. Leong, Long-Term Prognosis and Significance of the Sentinel Lymph Node in Head and Neck Melanoma Otolaryngology–Head and Neck Surgery. ,vol. 147, pp. 699- 706 ,(2012) , 10.1177/0194599812444268
Stanley P. L. Leong, Elizabeth Donegan, Wanda Heffernon, Susan Dean, Jeffrey A. Katz, Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Annals of Surgical Oncology. ,vol. 7, pp. 361- 366 ,(2000) , 10.1007/S10434-000-0361-X
Tohru Hoshida, Naohide Isaka, Jeroen Hagendoorn, Emmanuelle di Tomaso, Yen-Lin Chen, Bronislaw Pytowski, Dai Fukumura, Timothy P. Padera, Rakesh K. Jain, Imaging Steps of Lymphatic Metastasis Reveals That Vascular Endothelial Growth Factor-C Increases Metastasis by Increasing Delivery of Cancer Cells to Lymph Nodes: Therapeutic Implications Cancer Research. ,vol. 66, pp. 8065- 8075 ,(2006) , 10.1158/0008-5472.CAN-06-1392
Renato Santos de Oliveira Filho, Allisson Monteiro da Silva, Daniel Arcuschin de Oliveira, Gustavo Gianotto Oliveira, Fabio Xerfan Nahas, A biópsia de linfonodo sentinela não deve ser recomendada para pacientes portadores de melanoma espesso Revista do Colégio Brasileiro de Cirurgiões. ,vol. 40, pp. 127- 129 ,(2013) , 10.1590/S0100-69912013000200008
Merrick I. Ross, Sentinel Node Biopsy for Melanoma: An Update After Two Decades of Experience Seminars in Cutaneous Medicine and Surgery. ,vol. 29, pp. 238- 248 ,(2010) , 10.1016/J.SDER.2010.11.002
Javier Rangel, Mehdi Nosrati, Sima Torabian, Ladan Shaikh, Stanley P. L. Leong, Chris Haqq, James R. Miller, Richard W. Sagebiel, Mohammed Kashani-Sabet, Osteopontin as a molecular prognostic marker for melanoma. Cancer. ,vol. 112, pp. 144- 150 ,(2008) , 10.1002/CNCR.23147
Donald L Morton, Alistair J Cochran, John F Thompson, Robert Elashoff, Richard Essner, Edwin C Glass, Nicola Mozzillo, Omgo E Nieweg, Daniel F Roses, Harald J Hoekstra, Constantine P Karakousis, Douglas S Reintgen, Brendon J Coventry, He-jing Wang, Multicenter Selective Lymphadenectomy Trial Group, Sentinel node biopsy for early-stage melanoma - Accuracy and morbidity in MSLT-I, an international multicenter trial Annals of Surgery. ,vol. 242, pp. 302- 313 ,(2005) , 10.1097/01.SLA.0000181092.50141.FA
Mohammed Kashani-Sabet, Suraj Venna, Mehdi Nosrati, Javier Rangel, Antje Sucker, Friederike Egberts, Frederick L. Baehner, Jeff Simko, Stanley P.L. Leong, Chris Haqq, Axel Hauschild, Dirk Schadendorf, James R. Miller, Richard W. Sagebiel, A Multimarker Prognostic Assay for Primary Cutaneous Melanoma Clinical Cancer Research. ,vol. 15, pp. 6987- 6992 ,(2009) , 10.1158/1078-0432.CCR-09-1777
Michael E. Egger, Katherine M. Huber, Erik M. Dunki-Jacobs, Amy R. Quillo, Charles R. Scoggins, Robert C.G. Martin, Arnold J. Stromberg, Kelly M. McMasters, Glenda G. Callender, Incidence of Sentinel Lymph Node Involvement in a Modern, Large Series of Desmoplastic Melanoma Journal of the American College of Surgeons. ,vol. 217, pp. 37- 44 ,(2013) , 10.1016/J.JAMCOLLSURG.2013.05.006
J. Olah, R. Gyulai, I. Korom, E. Varga, A. Dobozy, Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas. British Journal of Dermatology. ,vol. 149, pp. 662- 663 ,(2003) , 10.1046/J.1365-2133.2003.05502.X